The Food and Drug Administration awarded a single-award indefinite delivery contract to Tuvli LLC to provide Oracle enterprise database and application server administration support services. The contract has a potential value of $95 million over a five-year period of performance from September 2022 through September 2027. Four firm fixed price delivery orders were awarded against the contract to support FDA's Digital Acceleration Service, Center for Drug Evaluation and Research, Center for Food Safety and Applied Nutrition, and Office of Information Management and Technology Oracle environments. Delivery order values range from $4.3 million to $16 million, with periods of performance through October 2027 and places of performance in Herndon, Virginia and Rockville, Maryland.
The originating solicitation sought proposals for the indefinite delivery contract to provide Oracle database and application server administration services across multiple task orders supporting over 250 Oracle databases across 18 servers in four environments. Proposals were evaluated based on technical approach, management plan, and pricing, with non-price factors considered more important than cost. The requirement was set aside for 8(a) small businesses and resulted in the single award to Tuvli LLC. Services will support FDA's critical information technology infrastructure and systems that manage regulated product and compliance information.